Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics

2017 ◽  
Vol 18 (9) ◽  
pp. 865-880 ◽  
Author(s):  
Sarah Allegra ◽  
Giovanna Fatiguso ◽  
Andrea Calcagno ◽  
Lorena Baietto ◽  
Ilaria Motta ◽  
...  
2002 ◽  
Vol 197 (1-2) ◽  
pp. 15-21 ◽  
Author(s):  
André G Uitterlinden ◽  
Yue Fang ◽  
Arjan P Bergink ◽  
Joyce B.J van Meurs ◽  
Hans P.T.M van Leeuwen ◽  
...  

2018 ◽  
Vol 19 (8) ◽  
pp. 701-707
Author(s):  
Jessica Cusato ◽  
Amedeo De Nicolò ◽  
Lucio Boglione ◽  
Fabio Favata ◽  
Alessandra Ariaudo ◽  
...  

2011 ◽  
Vol 22 (8) ◽  
pp. 752-757 ◽  
Author(s):  
Maria G. Stathopoulou ◽  
George V.Z. Dedoussis ◽  
George Trovas ◽  
Eirini V. Theodoraki ◽  
Aikaterini Katsalira ◽  
...  

2018 ◽  
Vol 37 (6) ◽  
pp. 2230-2237 ◽  
Author(s):  
Bule Shao ◽  
Shuying Jiang ◽  
Xiamusiye Muyiduli ◽  
Shuojia Wang ◽  
Minjia Mo ◽  
...  

2018 ◽  
Vol 69 (1) ◽  
pp. 25-31 ◽  
Author(s):  
Aylin Elkama ◽  
Bensu Karahalil

Abstract Multiple sclerosis (MS) is a complex inflammatory disease of the central nervous system (CNS) resulting in neurological impairment and disability. There is evidence that adequate vitamin D levels may lower the risk of MS development. The aetiology of MS is complex and involves both genetic and environmental factors. In fact, not one but several genes are believed to lead to the disease. As for environmental factors, one of the most important risk factors is vitamin D deficiency, which, in turn, is closely related to gene polymorphisms that play a role in vitamin D metabolism and regulation. However, information about these gene polymorphisms is quite contradictory. The aim of this review is to discuss the association between some of the vitamin D-related gene variants and MS.


2007 ◽  
Vol 9 (1) ◽  
Author(s):  
Marjorie L McCullough ◽  
Victoria L Stevens ◽  
William R Diver ◽  
Heather S Feigelson ◽  
Carmen Rodriguez ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-17 ◽  
Author(s):  
Alicja E. Grzegorzewska ◽  
Grzegorz Ostromecki ◽  
Paulina Zielińska ◽  
Adrianna Mostowska ◽  
Paweł P. Jagodziński

Background. T-cell cytokine gene polymorphisms and vitamin D pathway gene polymorphisms were evaluated as possibly associated with end-stage renal disease (ESRD) resulting from type 2 diabetes mellitus (DM) nephropathy.Methods. Studies were conducted among hemodialysis (HD) patients with ESRD due to type 2 DM nephropathy, chronic glomerulonephritis, chronic infective tubulointerstitial nephritis, and hypertensive nephropathy as well as in healthy subjects. A frequency distribution of T-cell-related interleukin (IL) genes (IL18rs360719,IL12Ars568408,IL12Brs3212227,IL4Rrs1805015,IL13rs20541,IL28Brs8099917,IL28B, and rs12979860) and vitamin D pathway genes (GC genes: rs2298849, rs7041, and rs1155563; VDR genes: rs2228570, rs1544410; and RXRA genes: rs10776909, rs10881578, and rs749759) was compared between groups.Results. No significant differences in a frequency distribution of tested polymorphisms were shown between type 2 DM nephropathy patients and controls. A difference was found inIL18rs360719 polymorphic distribution between the former group and chronic infective tubulointerstitial nephritic patients (Ptrend=0.033), which also differed in this polymorphism from controls (Ptrend=0.005).Conclusion. T-cell cytokine and vitamin D pathway gene polymorphisms are not associated with ESRD due to type 2 DM nephropathy in Polish HD patients.IL18rs360719 is probably associated with the pathogenesis of chronic infective tubulointerstitial nephritis.


Sign in / Sign up

Export Citation Format

Share Document